🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
50 Servings
Single Vitamin and Mineral Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

400 IU (100% DV)
✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)
RDA 0.015mg This product: 0.01mg UL 0.1mg
Calcium
600 mg (60% DV)

Other Ingredients

Microcrystalline Cellulose Maltodextrin Acacia Gum Croscarmellose Sodium Magnesium Stearate Silica Titanium Dioxide Hydroxypropyl Methylcellulose Triacetin Polydextrose Yellow #6 Lake

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (81% of products) Nutrient (71% of products) Approved Health (13% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one to two tablets daily, preferably with a meal or as directed by your healthcare professional.

⚠️ Warnings & Precautions

Keep out of the reach of children.

🧪 Formulation Notes

This product is manufactured under strict quality control guidelines, therefore purity and label potency are guaranteed.

Gluten free, no sugar, starch, preservatives, artificial flavors, wheat, yeast or corn added.

USA

You may reduce the risk of osteoporosis by taking calcium.

Additional Information

NDC 50268-150-15

Lab Tested Potency Assay Guaranteed Release

Store in a cool, dry place.

Product Details

UPC / SKU 5026815015
DSLD Entry Date 2024-01-24
Product Type Single Vitamin and Mineral
Form Tablet or Pill
Brand AvPAK
DSLD ID 306035
Data Updated 2026-04-11

Research Evidence

511 Research Sources
57 Avg Quality Score
266 Meta Analysis
95 Systematic Review
76 Rct
49 Clinical Trial
12 Guideline
4 Regulatory Source
2 Cochrane Review
2 Other
2 Narrative Review
1 Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Calcium →

Compare Similar Products

View all Calcium products →